Biotech China 2014

View Profile


Grant Support

Start year End year Title Source Position
1. 2006 2008 A Phase I Study of Biologic therapy (erlotinib and bevacizumab) added to chemoradiotherapy for advanced head and neck cancer. Genentech Inc P.I.
2. 2004 2008 Protection from Dose Limiting Toxicity of Chemoradiation for Head and Neck Cancer American College of Radiology
3. 2004 2008 Clinical Utility of Biomarkers for Stage III Non-small Cell Lung Carcinoma and Stage IV Head and Neck Cancer Department of Health
4. 2002 2007 Deputy Group Chair of the Radiation Therapy Oncology Group NIH/NCI Deputy Group Chairman and full Member Investigator
5. 2006 A Prospective, Longitudinal, Multicenter, Descriptive registry of patients receiving therapy other than surgical resection alone for newly diagnosed head and neck carcinoma. Imclone Inc Local PI
6. 2005 A Phase I Study of Alimta and Carboplatin and Radiation Therapy for Patients with Inoperable NSCLC Eli Lilly Inc. P.I.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.